Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioclarma
Torino, Piedmont, Italybioclarma.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Bioclarma develops and commercializes advanced molecular diagnostic kits for the detection of genetic markers in hematological malignancies, hereditary thrombophilia, coagulation disorders, and infectious diseases. Their flagship product is "Philadelphia Sensiquant," a high-sensitivity RT-PCR kit for BCR‑ABL transcript quantification in CML. They also offer direct PCR SNP detection kits ("Smart SNP"), FISH probes for chromosomal aberrations, COVID‑19 assays that do not require RNA extraction, as well as proteomics and Luminex-based multiplex analysis services. Their products are used by hospitals and research labs across Italy and internationally.
- Therapeutic areas
- Infectious DiseasesHematologyOncology
- Modalities
- Diagnostic kit (Real-Time PCR, ddPCR)Molecular diagnostic assayFISH probe
- Industry
- Molecular Diagnostics
02
Partnerships
Collaborates with leading research centersOfficial distributor of third-party solutions for scientific research/public healthPartners include major pharmaceutical companies/hospitals/universities as customers
Beyond the preview
Go deeper on Bioclarma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioclarma.